Standard or custom package
excellent quality and reliable supplier
*The following content is generated by AI and is for reference only.
Overview
Satraplatin is a second-generation oral platinum-based chemotherapy agent. Its core process involves the synthesis of a bis-acetato complex derived from cisplatin analogues. The chemical formula is C12H20N4O4Pt with CAS No. 116798-92-6.
Application
- Oncology Manufacturing: Production of clinical trial batches for metastatic castration-resistant prostate cancer.
- Pharmaceutical R&D: Supply of reference standards for comparative bioavailability studies.
- Contract Synthesis: Custom manufacturing of API intermediates for global pharmaceutical partners.
Precautions
Strictly controlled due to potential nephrotoxicity and myelosuppression. Storage requires desiccated conditions below 25°C in inert atmosphere packaging to prevent hydrolysis.